Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 783 of 6351
-
Insulin-spiked eye drops may ease stubborn dry eye in Sjögren's patients
Disease control CompletedIntroduction: Dry Eye Disease (DED) of autoimmune origin is often severe and resistant to conventional treatments, necessitating alternative therapeutic options. Autologous Serum Eye Drops (ASED) have gained recognition for their biochemical and biomechanical properties, which c…
Phase 3 • Sponsor: Instituto de Oftalmología Fundación Conde de Valenciana • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New drug combo aims to shrink breast tumors before surgery
Disease control Recruiting nowThis study is a randomized, open-label, multicenter clinical study for patients with early or locally advanced (T≥2cm, N0-3, M0) HER2-positive breast cancer, aiming to compare the peripheral blood ctDNA clearance of neoadjuvant pyrotinib + trastuzumab + docetaxel and pertuzumab +…
Phase 2 • Sponsor: Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Lung cancer drug adagrasib: which dose works best?
Disease control OngoingThis study will evaluate the efficacy of two dosing regimens of adagrasib (600 mg BID versus 400 mg BID) in patients with NSCLC with KRAS G12C mutation.
Phase 2 • Sponsor: Mirati Therapeutics Inc. • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
New hope for leukemia patients: asciminib trial launches
Disease control Recruiting nowTo learn if asciminib can help to control CML. The safety and effects of this drug will also be studied.
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Engineered immune cells take on Hard-to-Treat prostate cancer
Disease control OngoingThis is a Phase I, open-label dose finding study to assess the safety, tolerability, manufacturing feasibility, and preliminary efficacy of TmPSMA-02 CAR T cells in patients with metastatic castrate-resistant prostate cancer (mCRPC). Up to 4 total dose levels will be evaluated us…
Phase 1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
One jab for two bugs: pfizer tests combo COVID-Flu vaccine
Vaccine CompletedThe purpose of this clinical trial is to see if combining a licensed COVID-19 vaccine and a licensed influenza vaccine into a single shot is safe and can help produce antibodies to defend the body against both SARS-CoV-2 (the virus that causes COVID-19) and influenza. Participant…
Phase 2 • Sponsor: Pfizer • Aim: Vaccine
Last updated Jun 27, 2026 07:53 UTC
-
Could a heart pill boost exercise capacity in chronic heart failure?
Disease control CompletedHeart failure with reduced ejection fraction (HFrEF) is associated with impaired exercise capacity and abnormal exercise hemodynamics despite contemporary guideline-directed medical therapy (GDMT). Vericiguat, a soluble guanylate cyclase stimulator, has demonstrated clinical bene…
Sponsor: Argyrios Ntalianis • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New drug PLX038 targets aggressive brain tumors
Disease control Recruiting nowBackground: About 90,000 new cases of brain and spinal cord tumors are diagnosed annually in the United States. Most of these tumors are benign; however, about 30% are malignant, and 35% of people with malignant tumors in the brain and spinal cord will die within 5 years. Many o…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New pill could slow deadly lung scarring – early trial underway
Disease control Recruiting nowIfetroban prevents and treats lung fibrosis due to multiple causes (bleomycin, genetic, radiation). The safety and efficacy of oral ifetroban will be assessed in patients with IPF.
Phase 2 • Sponsor: Cumberland Pharmaceuticals • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Sound waves and a drug team up to attack deadly brain tumors
Disease control Recruiting nowPatients diagnosed with glioblastoma (GBM) are faced with limited treatment options. This pilot study will evaluate the safety and feasibility of combining an investigational drug called 5-ALA with neuronavigation-guided low-intensity focused ultrasound (LIFU) for patients who ha…
Phase 1 • Sponsor: Shayan Moosa, MD • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Triple therapy aims to tackle tough cancers
Disease control OngoingThe goal of this clinical trial is to test the safety and tolerability of anti-CD38 monoclonal antibody (mAb), daratumumab, in combination with KRAS vaccine (Targovax TG-01/Stimulon QS-21) when given with anti-PD-1 (programmed cell death protein 1) mAb (nivolumab) in patients wit…
Phase 2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could a stomach drug help fight pancreatic cancer?
Disease control OngoingThis is a Phase 2 study with an open labelled lead-in study to approximately treat 30 patients \[6 subjects for Lead-in and 24 for Phase 2\] enrolled with metastatic pancreatic cancer with combination therapy using standard of care first line therapy with GEM-NAB-P (GEM 1000mg/m2…
Phase 2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New pill D-2570 shows promise against stubborn psoriasis in early trial
Disease control CompletedThis is a randomized, double-blind, placebo-controlled, multicenter clinical trial in participants with moderate-to-severe plaque psoriasis .
Phase 2 • Sponsor: InventisBio Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Will a digital boost keep Post-COVID recovery on track?
Disease control CompletedInfection with SARS-CoV-2 virus leads to persistent symptoms for more than 12 weeks in 15% of cases ("post-COVID syndrome"). Symptoms like fatigue, dyspnoea, limitations in physical performance and activities, head ache, anxiety symptoms, and depression are heterogenous which lim…
Sponsor: Schön Klinik Berchtesgadener Land • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Virtual reality may ease Pre-Surgery anxiety in breast cancer patients
Symptom relief CompletedThis pilot randomized controlled trial (N=60) investigates the efficacy of a brief, combined Virtual Reality (VR) and mindfulness meditation intervention and a VR nature intervention for breast cancer patients in the immediate pre-surgical waiting period.
Sponsor: Fundacao Champalimaud • Aim: Symptom relief
Last updated Aug 27, 2026 00:00 UTC
-
Can navigation make hip replacements more precise?
Disease control OngoingAccurate reconstruction of the native hip parameters following total hip arthroplasty is associated with improved outcome. In order to improve ability for optimum reconstruction, 3-D templating software can be utilized that provide detailed information regarding native anatomy. I…
Sponsor: Ottawa Hospital Research Institute • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a single drug hold off multiple myeloma? new trial aims to find out
Disease control OngoingThis study is researching an investigational drug called linvoseltamab ("study drug") in participants at high risk of developing Multiple Myeloma (MM), a group commonly labeled as High-Risk Smoldering Multiple Myeloma (HR-SMM). The aim of the study is to understand the safety an…
Phase 2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New cocktail of three drugs targets Hard-to-Treat breast cancer
Disease control OngoingThe purpose of this study is to evaluate the safety and efficacy of the three-drug combination of tucatinib, trastuzumab, and eribulin in patients with de novo and recurrent unresectable metastatic HER-2/neu positive breast cancer as assessed by ORR, PFS and OS after prior treatm…
Phase 2 • Sponsor: Criterium, Inc. • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New TB vaccine candidate MTBVAC enters key safety trial in south africa
Vaccine Recruiting nowThe purpose of this study is to evaluate the safety and immunogenicity of MTBVAC in adolescents and adults living with and without HIV in South Africa
Phase 2 • Sponsor: HIV Vaccine Trials Network • Aim: Vaccine
Last updated Jun 27, 2026 11:00 UTC
-
Could a smart monitor help pregnant women with diabetes have healthier babies?
Disease control Recruiting nowThe prevalence of type 2 diabetes mellitus (T2DM) in women of childbearing age is increasing rapidly, and low glucose compliance leads to an increased risk of adverse pregnancy outcomes for mothers and infants during pregnancy in women with T2DM. Real-time continuous glucose moni…
Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC